Shujian Wu

3.3k total citations · 2 hit papers
46 papers, 2.6k citations indexed

About

Shujian Wu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shujian Wu has authored 46 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shujian Wu's work include Gut microbiota and health (7 papers), Protein Hydrolysis and Bioactive Peptides (7 papers) and Retinoids in leukemia and cellular processes (4 papers). Shujian Wu is often cited by papers focused on Gut microbiota and health (7 papers), Protein Hydrolysis and Bioactive Peptides (7 papers) and Retinoids in leukemia and cellular processes (4 papers). Shujian Wu collaborates with scholars based in China, United States and New Zealand. Shujian Wu's co-authors include Yu Ding, Kenneth J. Soprano, Qingping Wu, Edwin Clark, Andrew K. Godwin, José Baselga, Howard A. Burris, Tai W. Wong, Benjamin Tan and Christopher R. Garrett and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Shujian Wu

45 papers receiving 2.5k citations

Hit Papers

Expression of Epiregulin and Amphiregulin and K-ras Mutat... 2007 2026 2013 2019 2007 2022 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shujian Wu China 21 1.1k 1.0k 436 341 236 46 2.6k
James O’Kelly United States 30 1.4k 1.3× 477 0.5× 129 0.3× 492 1.4× 243 1.0× 59 3.0k
Junko Sugatani Japan 34 1.2k 1.1× 532 0.5× 259 0.6× 133 0.4× 288 1.2× 100 3.4k
Amarjit S. Naura United States 30 777 0.7× 678 0.7× 300 0.7× 98 0.3× 165 0.7× 64 2.0k
Stan Lightfoot United States 33 1.6k 1.4× 1.1k 1.0× 311 0.7× 204 0.6× 663 2.8× 107 3.0k
Vivienne E. Reeve Australia 34 800 0.7× 269 0.3× 250 0.6× 562 1.6× 122 0.5× 101 3.1k
Masao Miwa Japan 32 878 0.8× 385 0.4× 178 0.4× 157 0.5× 166 0.7× 83 2.7k
Masako Nakanishi United States 22 778 0.7× 458 0.4× 95 0.2× 148 0.4× 385 1.6× 52 1.9k
Larisa Nonn United States 30 1.5k 1.3× 411 0.4× 385 0.9× 640 1.9× 772 3.3× 69 2.9k
Dong Xiao China 34 2.8k 2.4× 451 0.4× 157 0.4× 172 0.5× 660 2.8× 88 3.8k
Wolfgang Hagmann Germany 23 626 0.6× 637 0.6× 186 0.4× 90 0.3× 245 1.0× 49 2.1k

Countries citing papers authored by Shujian Wu

Since Specialization
Citations

This map shows the geographic impact of Shujian Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujian Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujian Wu more than expected).

Fields of papers citing papers by Shujian Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shujian Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujian Wu. The network helps show where Shujian Wu may publish in the future.

Co-authorship network of co-authors of Shujian Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Shujian Wu. A scholar is included among the top collaborators of Shujian Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shujian Wu. Shujian Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calvo, Emiliano, Bernard Doger, Joan Carles, et al.. (2025). A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer. The Oncologist. 30(1). 2 indexed citations
5.
Chen, Guoxian, Lifang Fan, Jie Liu, & Shujian Wu. (2023). Machine learning-based predictive model for the differential diagnosis of ≤ 5 cm gastric stromal tumor and gastric schwannoma based on CT images. Discover Oncology. 14(1). 186–186. 1 indexed citations
6.
Lim, Emerson A., Michael T. Schweizer, Kim N., et al.. (2023). Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer. 21(3). 366–375. 32 indexed citations
7.
Wu, Shujian, Mengfei Chen, Yizhen Xie, et al.. (2023). Comparison of Neuroprotection and Regulating Properties on Gut Microbiota between Selenopeptide Val-Pro-Arg-Lys-Leu-SeMet and Its Native Peptide Val-Pro-Arg-Lys-Leu-Met In Vitro and In Vivo. Journal of Agricultural and Food Chemistry. 71(32). 12203–12215. 19 indexed citations
9.
Wu, Shujian, Qingping Wu, Juan Wang, et al.. (2022). Novel Selenium Peptides Obtained from Selenium-Enriched Cordyceps militaris Alleviate Neuroinflammation and Gut Microbiota Dysbacteriosis in LPS-Injured Mice. Journal of Agricultural and Food Chemistry. 70(10). 3194–3206. 49 indexed citations
10.
Wu, Shujian, Xiyu Liao, Zhenjun Zhu, et al.. (2022). Antioxidant and anti-inflammation effects of dietary phytochemicals: The Nrf2/NF-κB signalling pathway and upstream factors of Nrf2. Phytochemistry. 204. 113429–113429. 66 indexed citations
11.
Zhu, Zhenjun, Rui Huang, Juan Wang, et al.. (2022). Polysaccharide from Agrocybe cylindracea prevents diet-induced obesity through inhibiting inflammation mediated by gut microbiota and associated metabolites. International Journal of Biological Macromolecules. 209(Pt A). 1430–1438. 69 indexed citations
12.
Lipardi, Concetta, C. Gregory Elliott, Lloyd Haskell, et al.. (2021). Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis. Clinical and Applied Thrombosis/Hemostasis. 27. 2975234820–2975234820. 1 indexed citations
13.
14.
Zhou, Juanjuan, Mengfei Chen, Shujian Wu, et al.. (2020). A review on mushroom-derived bioactive peptides: Preparation and biological activities. Food Research International. 134. 109230–109230. 105 indexed citations
15.
Wu, Shujian, et al.. (2019). Preparation of Hydrolysate with Umami from White Shrimp (Penaeus vannamei) Head. 40(4). 34–42. 1 indexed citations
16.
Sun, Yanjing, Qi Xuan, Shujian Wu, et al.. (2013). Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma. Genetics and Molecular Research. 12(2). 1045–1053. 14 indexed citations
17.
Garrett, Christopher, Edwin Clark, Mark Basik, et al.. (2007). Expression of epiregulin and amphiregulin and K-RAS mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab (Erbitux ®). Cancer Research. 67. 5670–5670. 3 indexed citations
18.
Tsuchihashi, Zenta, et al.. (2006). Assessment of tissue biomarkers following anti-CD137 treatment in the EMT-6 mouse tumor model.. Cancer Research. 66. 1306–1306. 2 indexed citations
19.
Lee, Ning, Jian Chen, Lucy Sun, et al.. (2003). Expression and Characterization of Human Transient Receptor Potential Melastatin 3 (hTRPM3). Journal of Biological Chemistry. 278(23). 20890–20897. 170 indexed citations
20.
Wu, Shujian, et al.. (1996). Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.. PubMed. 12(3). 621–9. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026